| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
|
28.03.2025 11:11:00
|
These Are My 3 Worst-Performing Stocks So Far in 2025 -- and the One I'm Buying More of Now
It's hard to believe, but the first quarter of 2025 is rapidly coming to a close. After doing a quick portfolio checkup, I found that I have stocks that have gained as much as 40% already this year, but I also have a few that are down nearly 30%.This is an expected part of investing, especially when it comes to growth stocks. In some cases, beaten-down stocks create an excellent buying opportunity, but that isn't always the case. With that in mind, here's a rundown of the three worst-performing stocks in my portfolio so far this year, why each of them has performed so poorly, and which one I think is the best buying opportunity of the three right now.Teva Pharmaceutical (NYSE: TEVA) is my worst-performing stock so far in 2025, down 27% in less than three months as of this writing. And the big reason is the company's fourth quarter earnings report, which sent the stock down by double digits in a single day.Continue readingWeiter zum vollständigen Artikel bei MotleyFool